1. Home
  2. KLXE vs IMAB Comparison

KLXE vs IMAB Comparison

Compare KLXE & IMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • IMAB
  • Stock Information
  • Founded
  • KLXE 2018
  • IMAB 2014
  • Country
  • KLXE United States
  • IMAB United States
  • Employees
  • KLXE N/A
  • IMAB N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • IMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • IMAB Health Care
  • Exchange
  • KLXE Nasdaq
  • IMAB Nasdaq
  • Market Cap
  • KLXE 89.2M
  • IMAB 87.2M
  • IPO Year
  • KLXE N/A
  • IMAB 2020
  • Fundamental
  • Price
  • KLXE $4.54
  • IMAB $0.99
  • Analyst Decision
  • KLXE Hold
  • IMAB Strong Buy
  • Analyst Count
  • KLXE 1
  • IMAB 3
  • Target Price
  • KLXE $4.50
  • IMAB $8.00
  • AVG Volume (30 Days)
  • KLXE 186.8K
  • IMAB 270.7K
  • Earning Date
  • KLXE 03-05-2025
  • IMAB 03-13-2025
  • Dividend Yield
  • KLXE N/A
  • IMAB N/A
  • EPS Growth
  • KLXE N/A
  • IMAB N/A
  • EPS
  • KLXE N/A
  • IMAB N/A
  • Revenue
  • KLXE $738,000,000.00
  • IMAB $3,313,984.00
  • Revenue This Year
  • KLXE N/A
  • IMAB N/A
  • Revenue Next Year
  • KLXE $4.79
  • IMAB N/A
  • P/E Ratio
  • KLXE N/A
  • IMAB N/A
  • Revenue Growth
  • KLXE N/A
  • IMAB N/A
  • 52 Week Low
  • KLXE $4.18
  • IMAB $0.84
  • 52 Week High
  • KLXE $9.80
  • IMAB $2.00
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 35.29
  • IMAB 43.19
  • Support Level
  • KLXE $5.04
  • IMAB $1.03
  • Resistance Level
  • KLXE $6.16
  • IMAB $1.10
  • Average True Range (ATR)
  • KLXE 0.51
  • IMAB 0.06
  • MACD
  • KLXE -0.19
  • IMAB -0.01
  • Stochastic Oscillator
  • KLXE 2.15
  • IMAB 7.58

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

Share on Social Networks: